Nefazodone in the treatment of patients with post-traumatic stress disorder

References

• Shavlev, Arieh Y. What is posttraumatic stress disorder?' Gun. Bydriatry62\(Suppl. 17), 4–9 (2001).
   Google Scholar
• •Review of PTSD and patient assessment.
   Google Scholar
• Voris, JC, Voris CT, Kaltsounis J. Use of nefazodone in the treatment of posttraumatic stress disorder. Veterans Health System 61–65 (2001).
   Google Scholar
• •Retrospective review showing nefazodone as most frequently selected antidepressant for treating PTSD.
   Google Scholar
• Watanabe MD, Finley PR. Psychiatric Disarlers. Applied therapeutics the clinical use of drugs; 17th Ed. 74.33-35 (2001).
   Google Scholar
• Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. Gun. Psychiatry 61 (Suppl. 5), 4–12 (2000).
   Google Scholar
• Kessler RC, Sonnega A, Bromet E et al Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry52, 1048–1060 (1995).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disarlers, Fourth Edition. American Psychiatric Association, Washington, DC, USA (1994).
   Google Scholar
• Gillin JC, Smith-Vaniz A, Schnierow B et al An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. j Clin. PTchiatry 62 (10), 789–796 (2001). Showed significant improvement in PTSD and depression rating scales.
   Google Scholar
• Yehuda R. Post-traumatic stress disorder. N Engl. Med. 346, 108–114 (2002).
   PubMed Web of Science ®Google Scholar
• Davidson JRT. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up and predictors of outcome. j Gun. Psychiatry 61 (Suppl. 5), 52 (2000).
   Google Scholar
• Foa EB, Davidson JRT, Frances A. Expert Consensus Guideline Series. Treatment of posttraumatic stress disorder. j Clin. Psychiatry 60\(Suppl. 16), 6–75 (1999).
   Google Scholar
• Brady K, Perlstein T, Asnis GM et al Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAIVIA 283, 1837–1844 (2000).
   PubMed Web of Science ®Google Scholar
• Davidson J, Peristein T, Londborg P et al Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled
   Google Scholar
• •• study. Am. J. Psychiatry 158, 1974–1981 (2001).
   Google Scholar
• Tucker P, Zaninelli, Yehuda R et al Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. Clin. Psychiatry 62,860–868 (2001).
   PubMed Web of Science ®Google Scholar
• Marshall RD, Beebe KL, Oldham M et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am. J. Psychiatry 158, 1982–1988 (2001).
   PubMed Web of Science ®Google Scholar
• Bristol-Myers Squibb prescribing information package insert for nefazodone (Serzonel .
   Google Scholar
• Fuller MA, Sajatovic M. Nefazodone. Lexicomp Drug Information for Mental Health. 386–387 (2001).
   Google Scholar
• Robinson DS, Roberts DL, Smith JM et al. The safety profile of nefazodone. j Clin. fiychiatry57\(Suppl. 2), 31–38 (1996).
   Google Scholar
• Dunner DL, Laird LK. Comparative safety and tolerability of nefazodone. j Clin. Rychiatry63\(Suppl. 1), 33–41 (2002). Comparison of adverse events with nefazodone and other antidepressants.
   Google Scholar
• Feiger A, Kiev A, Shrivastava RK et al. Nefazodone versussertraline in out-patients with major depression: focus on efficacy, tolerability and effects on sexual function and satisfaction. J. Clin. Psychiatry 57\(Suppl. 2), 53–62 (1996).
   Google Scholar
• Ferguson JM, Shrivastava R, Stahl SM et al Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. j Clin. Ptychiatry62, 24–29 (2001).
   PubMed Web of Science ®Google Scholar
• Davis LL, Nugent AL, Murray J et al. Nefazodone treatment for chronic posttraumatic stress disorder: an open trial. Clin. Ptychopharmacol 20(2), 159–164 (2000). Significant improvement in CAPS score.
   Google Scholar
• Zisook S, Chentsova-Dutton YE, Smith- Vaniz A et al Nefazodone in patients with treatment-refractory posttraumatic stress disorder. J. Clin. fiychiatry61 (3), 203–208 (2000). Reported significant improvement in PTSD symptoms.
   Google Scholar
• Raskind MA, Dobie DJ, Kanter ED et al The al-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J. Clin. Psychiatry 61, 129–133 (2000).
   Google Scholar
• Rickels K, Schweizer E, Clary C et al Nefazodone and imipramine in major depression: a placebo-controlled trial. BE J. fiychiatry164 (4), 802–805 (1994) .
   PubMedGoogle Scholar
• Feighner JP, Pambakian R, Fowler RC et al A comparison of nefazodone, imipramine and placebo in patients with moderate to severe depression. Ptychopharmacol Bull 25(2), 219–221 (1989).
   PubMed Web of Science ®Google Scholar
• Fontaine R, Ontiveros A, Elie R et al A double-blind comparison of nefazodone, imipramine and placebo in major depression. J. Clin. Ptychiatry55,234–241 (1994).
   PubMed Web of Science ®Google Scholar
• Fawcett J, Marcus RN, Anton SF et al Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J. Clin. Ptychiatry56, 37–42 (1995).
   PubMed Web of Science ®Google Scholar
• Papp L, Coplan JD, Martinez JM et al Efficacy of open-label nefazodone treatment in patients with panic disorder. J. Clin. Ptychopharmacol 20,544–546 (2000).
   PubMed Web of Science ®Google Scholar
• Mellman TA, David D, Barza L. Nefazodone treatment and dream reports in chronic PTSD. Depression Anxiety9, 146–148 (1999).
   Google Scholar
• Armitage R. Effects of antidepressant treatment on sleep EEG in depression. fiychopharmacol 12\(Suppl. 1), 22–25 (1996).
   Google Scholar
• Armitage R, Yonkers K, Cole D et al A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed out-patients. j Clin. Psychopharmacol 17,161–168 (1997).
   PubMed Web of Science ®Google Scholar
• Rush AJ, Armitage R, Gillen JC et al Comparative effects of nefazodone and fluoxetine on sleep in out-patients with major depression disorder. Biol. Psychiatry 44,3–14 (1998).
   PubMed Web of Science ®Google Scholar
• Davidson JRT, Weisler RII, Malik ML et al Treatment of posttraumatic stress disorder with nefazodone. Int. Clin. Psychopharmacol 13(3), 111–113 (1998). Significant improvement in PTSD symptoms within 12 weeks.
   Google Scholar
• Hertzberg MA, Feldman ME, Beckham JC. Open trial of nefazodone for combat-related posttraumatic stress disorder. J. Clin. Psychiatty 59 (9), 460–464 (1998) .
   Google Scholar
• Hildago R, Hertzberg MA, Mellman T et al Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int. Clin. Ptychopharmacol 14,61–68 (1999)
   PubMed Web of Science ®Google Scholar
• Voris JC, Shaurette GN, Sebastian PS et al Nefazodone single versustwice daily dosing. Pharmacotherapy18(2), 379–380 (1998).
   PubMed Web of Science ®Google Scholar